EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $96,518 | +260.0% | 11,094 | +21.6% | 0.00% | – |
| Q1 2023 | $26,813 | +1240.6% | 9,120 | +2880.4% | 0.00% | – |
| Q3 2022 | $2,000 | -96.8% | 306 | -96.1% | 0.00% | – |
| Q2 2022 | $62,000 | -36.7% | 7,919 | -1.9% | 0.00% | – |
| Q1 2022 | $98,000 | +34.2% | 8,072 | +35.7% | 0.00% | – |
| Q4 2021 | $73,000 | -85.9% | 5,950 | -89.7% | 0.00% | -100.0% |
| Q2 2021 | $518,000 | -17.4% | 57,653 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $627,000 | +1040.0% | 61,755 | +637.3% | 0.00% | – |
| Q4 2020 | $55,000 | – | 8,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |